Early treatment and toxicity outcomes for small posterior uveal melanomas treated using custom loaded eye plaques

Keyphrases

• Cancer Mortality 9%
• Cataract 9%
• Clinically Significant 9%
• Collaborative Ocular Melanoma Study 9%
• During Treatment 9%
• Early Toxicity 100%
• Early Treatment 100%
• Eye Plaque 100%
• Iodine-125 9%
• Local Metastasis 9%
• Local Recurrence 9%
• Ocular Cancer 9%
• Operative 9%
• Ophthalmologist 9%
• Partially Loaded 36%
• Patient Selection 9%
• Plaque 100%
• Posterior Uveal Melanoma 100%
• Radiation Retinopathy 9%
• Recurrence or Metastasis 9%
• Retrospective Analysis 9%
• Statistically Significant Difference 9%
• Toxicity Outcomes 100%
• Treatment Outcome 100%
• Tumor 18%
• Tumor Control 27%
• Tumor Toxicity 9%
• Uveal Melanoma 9%
• Visual Loss 18%

Medicine and Dentistry

• Cataract 33%
• Eye Cancer 33%
• Eye Melanoma 33%
• Iodine 125 33%
• Malignant Neoplasm 33%
• Metastatic Carcinoma 33%
• Neoplasm 100%
• Radiation Retinopathy 33%
• Recurrent Disease 66%
• Tumor 66%
• Uvea Melanoma 100%
• Visual Impairment 66%

Nursing and Health Professions

• Cancer Control 100%
• Cataract 33%
• Collaboration 33%
• Economic and Social Development 33%
• Eye Melanoma 33%
• Iodine-125 33%
• Malignant Neoplasm 33%
• Ophthalmologist 33%
• Recurrent Disease 66%
• Retinopathy 33%
• Uvea Melanoma 100%
• Visual Impairment 66%